Springer The New Public Health and STD/HIV Prevention: Personal, Public and Health Systems Approaches

This book advances the argument that the public health discourse in general and the STI/HIV prevention discourse in particular must evolve and expand to include strategic approaches to epidemiology and prevention. From the Back Cover Despite effective approaches to prevention, STD and HIV infection rates remain fairly constant. Targeting, implementation, and monitoring of interventions have posed widespread problems, and the recent spate of cuts to prevention budgets has made these roadblocks even more challenging. It is clear that working in sexual health requires both a deeper understanding of STI/HIV epidemiology and an ongoing quest for up-to-date, realistic prevention strategies.   The New Public Health and STD/HIV Prevention offers readers leading-edge access to both. Focusing on social determinants of sexual health, at-risk populations, critical factors in approaches to prevention, and reviews of new research, this authoritative volume explores areas as varied as HPV prevention, technology-based interventions, migration as a factor in disease transmission, and competencies key to effective leadership in the field. Dispatches from the frontlines of theory, research, and practice in the U.S. and abroad include:   Personal risk, public impact: balancing individual rights and STD/HIV prevention. Distribution of prevention resources and its impact on sexual health. Prevention measures in diverse populations of women. Toward a better approach to preventive interventions with men who have sex with men. Adolescent sexual health and STIs. Reducing disparities in sexual health: lessons from the campaign to eliminate infectious syphilis.   Public health professionals of all backgrounds interested in or working in improving sexual health will find The New Public Health and STD/HIV Prevention an indispensable guide to conceptualizing the problems and clarifying possible solutions. About the Author Sevgi O. Aral, MA, MS, PhD, has been the Associate Director for Science in the Division of STD Prevention, Centers for Disease Control since 1993.  She holds professorial appointments at the University Of Washington in Seattle; University of Manitoba in Winnipeg and Emory University in Atlanta. Dr. Aral has authored more than 230 scientific articles and edited 16 journal issues and 2 books.  Dr. Aral has served on many national and international work groups, boards and committees; and has consulted for the World Health Organization, The European Union and the World Bank.  She has received the ASTDA Achievement Award and the Thomas Parran Award. Over the years, her research interests have included social and behavioral aspects of sexually transmitted disease epidemiology and prevention; including gender, age and race effects; mixing patterns; sexual and social networks; contextual factors; social determinants and most recently, program science. Dr. Aral came to the Centers for Disease Control in 1978 from Middle East Technical University in Ankara, Turkey where she was the chair of the Department of Social Sciences. Kevin Fenton, MD, PhD, FFPH, is the Director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC), a position he has held since November 2005. Previously, he was chief of CDC’s National Syphilis Elimination Effort and has worked in research, epidemiology, and the prevention of HIV and other STDs since 1995. Before coming to CDC, he was the Director of the HIV and STI Department at the United Kingdom’s Health Protection Agency. At CDC, Dr. Fenton has led a number of critical efforts to address the U.S. HIV epidemic, including the release of revised HIV screening recommendations to make HIV testing a routine part of medical care for all Americans, and the implementation of a new surveillance system to provide more precise estimates of new HIV infections in the United States. Under Dr. Fenton’s le